Form 8-K - Current report:
SEC Accession No. 0001104659-26-112399
Filing Date
2026-09-30
Accepted
2026-09-30 17:09:31
Documents
11
Period of Report
2026-09-30
Items
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2626722d1_8k.htm   iXBRL 8-K 26104
  Complete submission text file 0001104659-26-112399.txt   188562

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20260930.xsd EX-101.SCH 3026
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20260930_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20260930_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2626722d1_8k_htm.xml XML 3005
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 261427925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)